Isolation of anti-HIV-1 lignans from Larrea tridentata by counter-current chromatography

J Chromatogr A. 1996 Jan 8;719(2):353-64. doi: 10.1016/0021-9673(95)00727-x.

Abstract

Several lignans, mostly new, were isolated from Larrea tridentata by assay-guided counter-current chromatography (CCC). Using the secreted alkaline phosphatase bioassay of HIV Tat transactivation and the two-phase hexane-ethyl acetate-methanol-water solvent system, two major components (Gr and Lo) were identified as anti-HIV active principles. The chemical structures of the constituents of Gr (G1-G4) and Lo (L1-L4) were determined by GC-MS and NMR. After optimization of isolation conditions, a large-scale isolation with the chloroform-methanol-water system yielded five constituents (FB1-FB5). The most predominant anti-HIV compound FB2 (denoted Malachi 4:5-6 or mal.4), which occurs in 0.23% yield, was separated from its FB1 isomer (0.13% yield). Compound FB4 and two tricyclic lignans (FB3 and FB5) were also isolated in a substantial amount for further testing of their anti-HIV activities. These compounds may represent a new class of anti-HIV agents with important clinical relevance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antiviral Agents / isolation & purification*
  • Antiviral Agents / pharmacology
  • Chromatography, Thin Layer / methods*
  • Gas Chromatography-Mass Spectrometry
  • Gene Products, tat / physiology
  • HIV-1 / drug effects*
  • Lignans / isolation & purification*
  • Lignans / pharmacology
  • Magnetic Resonance Spectroscopy
  • Pilot Projects
  • Plants, Medicinal / chemistry*
  • Transcriptional Activation / physiology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Antiviral Agents
  • Gene Products, tat
  • Lignans
  • tat Gene Products, Human Immunodeficiency Virus